Will Palantir Crash?
AI and data analytics software major Palantir (NASDAQ:PLTR) has been…
Sell
39
HR Quote, Financials, Valuation and Earnings
Last price:
$14.86
Seasonality move
:
-0.04%
Day range:
$14.85 - $15.08
52-week range:
$14.09 - $18.90
Dividend yield:
8.33%
P/E ratio:
--
P/S ratio:
4.36x
P/B ratio:
1.03x
Volume:
2.9M
Avg. volume:
3.1M
1-year change:
-9.82%
Market cap:
$5.2B
Revenue:
$1.2B
EPS (TTM):
-$1.09
Analysts' Opinion
-
Consensus RatingHealthcare Realty Trust has received a consensus rating of Hold. The company's average rating is a Hold based on 1 Buy rating, 9 Hold ratings, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $16.78, Healthcare Realty Trust has an estimated upside of 12.75% from its current price of $14.88.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $14.00 representing 100% downside risk from its current price of $14.88.
Fair Value
-
According to the consensus of 11 analysts, Healthcare Realty Trust has 12.75% upside to fair value with a price target of $16.78 per share.
HR vs. S&P 500
-
Over the past 5 trading days, Healthcare Realty Trust has overperformed the S&P 500 by 2.3% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Healthcare Realty Trust does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Healthcare Realty Trust revenues have been falling on a year-over-year basis for 6 quarters in a row. In the most recent quarter Healthcare Realty Trust reported revenues of $299M.
Earnings Growth
-
Healthcare Realty Trust earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Healthcare Realty Trust reported earnings per share of -$0.13.
Enterprise value:
10B
EV / Invested capital:
1.01x
Price / LTM sales:
4.36x
EV / EBIT:
--
EV / Revenue:
8.19x
PEG ratio (5yr expected):
-0.06x
EV / Free cash flow:
48.68x
Price / Operating cash flow:
25.93x
Enterprise value / EBITDA:
18.79x
Gross Profit (TTM):
$754M
Return On Assets:
-3.44%
Net Income Margin (TTM):
-31.81%
Return On Equity:
-6.81%
Return On Invested Capital:
-3.66%
Operating Margin:
6.53%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $1.1B | $1.3B | $1.2B | $326.8M | $299M | |
| Gross Profit | $698.2M | $820.7M | $754M | $205.7M | $184M | |
| Operating Income | $73.9M | $55.6M | $43.3M | $12.8M | $19.5M | |
| EBITDA | $723.7M | $507.8M | $532.3M | -$65.8M | $170.8M | |
| Diluted EPS | -$0.21 | -$1.33 | -$1.09 | -$0.82 | -$0.13 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $76.7M | $37.7M | $443.1M | $57.1M | $32.4M | |
| Total Assets | $3.9B | $4.4B | $13.6B | $12.3B | $10.5B | |
| Current Liabilities | $74.7M | $403.8M | $1.2B | $283.9M | $239.3M | |
| Total Liabilities | $1.9B | $2.2B | $6.1B | $5.8B | $5.3B | |
| Total Equity | $2B | $2.2B | $7.5B | $6.5B | $5.1B | |
| Total Debt | $1.6B | $1.9B | $5.4B | $5.1B | $4.7B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $298.2M | $506.8M | $473.3M | $76.2M | $47.8M | |
| Cash From Investing | $1.8B | $249M | $920.7M | -$58.6M | -$38.8M | |
| Cash From Financing | -$2.1B | -$779.6M | -$1.4B | -$17.1M | -$52.1M | |
| Free Cash Flow | $97.8M | $285.5M | $205.5M | $25.8M | -$21.3M | |
HR
Sector
Market Cap
$5.2B
$1B
Price % of 52-Week High
78.73%
83.08%
Dividend Yield
8.33%
3.15%
Shareholder Yield
16.97%
4.07%
1-Year Price Total Return
-9.82%
--
Beta (5-Year)
0.750
0.756
Dividend yield:
8.33%
Annualized payout:
$1.24
Payout ratio:
-115.41%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$14.67
200-day SMA
Sell
Level
$16.72
Bollinger Bands (100)
Sell
Level
14.97 - 16.77
Chaikin Money Flow
Buy
Level
268.5M
20-day SMA
Buy
Level
$14.57
Relative Strength Index (RSI14)
Buy
Level
52.70
ADX Line
Buy
Level
21.64
Williams %R
Neutral
Level
-21.7822
50-day SMA
Sell
Level
$15.07
MACD (12, 26)
Sell
Level
-0.08
25-day Aroon Oscillator
Sell
Level
-68
On Balance Volume
Neutral
Level
99.8M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.7352)
Sell
CA Score
(Annual)
Level (-0.5074)
Buy
Beneish M-Score
(Annual)
Level (-3.225)
Buy
Momentum Score
Level (8)
Buy
Ohlson Score
Level (-0.4831)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (2)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Healthcare Realty Trust Inc is a healthcare facility real estate investment trust. The company focuses on owning, leasing, and managing outpatient facilities and other healthcare properties. The company works to invest in outpatient facilities that are integral to a hospital's operations. It generates all of its revenue in the United States.
Stock Forecast FAQ
In the current month, HR has received 1 Buy ratings 9 Hold ratings, and 1 Sell ratings. The HR average analyst price target in the past 3 months is $16.78.
-
Where Will Healthcare Realty Trust Stock Be In 1 Year?
According to analysts, the consensus estimate is that Healthcare Realty Trust share price will rise to $16.78 per share over the next 12 months.
-
What Do Analysts Say About Healthcare Realty Trust?
Analysts are divided on their view about Healthcare Realty Trust share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Healthcare Realty Trust is a Sell and believe this share price will drop from its current level to $14.00.
-
What Is Healthcare Realty Trust's Price Target?
The price target for Healthcare Realty Trust over the next 1-year time period is forecast to be $16.78 according to 11 Wall Street analysts, 1 of them rates the stock a Buy, 1 rates the stock a Sell, and 9 analysts rate the stock a Hold.
-
Is HR A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Healthcare Realty Trust is a Hold. 9 of 11 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of HR?
You can purchase shares of Healthcare Realty Trust via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Healthcare Realty Trust shares.
-
What Is The Healthcare Realty Trust Share Price Today?
Healthcare Realty Trust was last trading at $14.86 per share. This represents the most recent stock quote for Healthcare Realty Trust. Yesterday, Healthcare Realty Trust closed at $14.88 per share.
-
How To Buy Healthcare Realty Trust Stock Online?
In order to purchase Healthcare Realty Trust stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Target’s Dividend Worth Buying?
Retail giant Target (NYSE:TGT) has been through an extremely volatile…
Where Will AST SpaceMobile Be In 5 Years?
Ever tried to send a text from the Nevada desert…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 41x
Buy
60
Is NVDA Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 49x
Sell
37
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
49
RGC alert for Jun 17
Regencell Bioscience Holdings [RGC] is up 30.47% over the past day.
Buy
59
SYM alert for Jun 17
Symbotic [SYM] is down 3.91% over the past day.
Sell
43
TNXP alert for Jun 17
Tonix Pharmaceuticals Holding [TNXP] is down 5.6% over the past day.
